Literature DB >> 4027940

Multiple myeloma and family history of cancer. A case-control study.

C C Bourguet, S Grufferman, E Delzell, E R DeLong, H J Cohen.   

Abstract

A hospital-based case-control study was done to examine the hypothesis that persons with a family history of multiple myeloma (MM) or other cancers are at increased risk of multiple myeloma. Study members were 439 cases of multiple myeloma and 1317 matched controls seen at the Duke University Medical Center. Only 3 cases and 4 controls reported multiple myeloma in their families. The relative risk (RR) was 2.3, but the 95% confidence interval (CI) was 0.5-10.1, allowing no firm conclusion about the risk associated with familial MM. A family history of cancer of any type resulted in a relative risk of MM of 1.4 (CI: 1.1-1.8). This association was strongest (RR = 2.5, CI: 1.1-5.3) among young study members (age less than or equal to 49). A family history of hematologic malignancy (ICD 200-208) resulted in a RR of 2.4 (95% CI: 1.4-4.0). The data also suggested that a family history of lung cancer, breast cancer, and genitourinary cancer may be associated with increased risk of myeloma in older persons.

Entities:  

Mesh:

Year:  1985        PMID: 4027940     DOI: 10.1002/1097-0142(19851015)56:8<2133::aid-cncr2820560842>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

Review 1.  Inherited genetic susceptibility to multiple myeloma.

Authors:  G J Morgan; D C Johnson; N Weinhold; H Goldschmidt; O Landgren; H T Lynch; K Hemminki; R S Houlston
Journal:  Leukemia       Date:  2013-11-19       Impact factor: 11.528

2.  Risk of solid tumors and myeloid hematological malignancies among first-degree relatives of patients with monoclonal gammopathy of undetermined significance.

Authors:  Sigurdur Y Kristinsson; Lynn R Goldin; Magnus Björkholm; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-06-22       Impact factor: 9.941

3.  Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers.

Authors:  A R Schnatter; T W Armstrong; M J Nicolich; F S Thompson; A M Katz; W W Huebner; E D Pearlman
Journal:  Occup Environ Med       Date:  1996-11       Impact factor: 4.402

4.  Direct evidence for a polygenic etiology in familial multiple myeloma.

Authors:  Britt-Marie Halvarsson; Anna-Karin Wihlborg; Mina Ali; Konstantinos Lemonakis; Ellinor Johnsson; Abhishek Niroula; Carrie Cibulskis; Niels Weinhold; Asta Försti; Evren Alici; Christian Langer; Michael Pfreundschuh; Hartmut Goldschmidt; Ulf-Henrik Mellqvist; Ingemar Turesson; Anders Waage; Kari Hemminki; Todd Golub; Hareth Nahi; Urban Gullberg; Markus Hansson; Björn Nilsson
Journal:  Blood Adv       Date:  2017-04-07

Review 5.  Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.

Authors:  Alexandra J Greenberg; S Vincent Rajkumar; Celine M Vachon
Journal:  Blood       Date:  2012-02-21       Impact factor: 22.113

6.  Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.

Authors:  Celine M Vachon; Robert A Kyle; Terry M Therneau; Barbara J Foreman; Dirk R Larson; Colin L Colby; Tara K Phelps; Angela Dispenzieri; Shaji K Kumar; Jerry A Katzmann; S Vincent Rajkumar
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

7.  Occupational and other environmental factors and multiple myeloma: a population based case-control study.

Authors:  M Eriksson; M Karlsson
Journal:  Br J Ind Med       Date:  1992-02

8.  Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study.

Authors:  M Eriksson; B Hållberg
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

9.  Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium.

Authors:  Leah H Schinasi; Elizabeth E Brown; Nicola J Camp; Sophia S Wang; Jonathan N Hofmann; Brian C Chiu; Lucia Miligi; Laura E Beane Freeman; Silvia de Sanjose; Leslie Bernstein; Alain Monnereau; Jacqueline Clavel; Guido J Tricot; Djordje Atanackovic; Pierluigi Cocco; Laurent Orsi; James A Dosman; John R McLaughlin; Mark P Purdue; Wendy Cozen; John J Spinelli; Anneclaire J de Roos
Journal:  Br J Haematol       Date:  2016-06-22       Impact factor: 6.998

10.  Inherited predisposition to multiple myeloma.

Authors:  Divya T Koura; Amelia A Langston
Journal:  Ther Adv Hematol       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.